Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate-day lenograstim to manage persistent moderate neutropenia in solid tumor patients on chemotherapy
2007-002742-38Phase 3Active
- Sponsor
- Centre François Baclesse
- Start
- Jun 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of lenograstim in Nonhematologic neoplasms (2 arms), sponsored by Centre François Baclesse. Started Jun 2007; status: active.
02
Drugs
lenograstim
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on 2007-002742-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002742-38.